These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17043637)

  • 1. Urokinase receptor primes cells to proliferate in response to epidermal growth factor.
    Jo M; Thomas KS; Takimoto S; Gaultier A; Hsieh EH; Lester RD; Gonias SL
    Oncogene; 2007 Apr; 26(18):2585-94. PubMed ID: 17043637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic assembly of the urokinase-type plasminogen activator signaling receptor complex determines the mitogenic activity of urokinase-type plasminogen activator.
    Jo M; Thomas KS; Marozkina N; Amin TJ; Silva CM; Parsons SJ; Gonias SL
    J Biol Chem; 2005 Apr; 280(17):17449-57. PubMed ID: 15728176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGF receptor transactivation by urokinase receptor stimulus through a mechanism involving Src and matrix metalloproteinases.
    Guerrero J; Santibañez JF; González A; Martínez J
    Exp Cell Res; 2004 Jan; 292(1):201-8. PubMed ID: 14720519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crosstalk between the urokinase-type plasminogen activator receptor and EGF receptor variant III supports survival and growth of glioblastoma cells.
    Hu J; Jo M; Cavenee WK; Furnari F; VandenBerg SR; Gonias SL
    Proc Natl Acad Sci U S A; 2011 Sep; 108(38):15984-9. PubMed ID: 21896743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor receptor-dependent and -independent cell-signaling pathways originating from the urokinase receptor.
    Jo M; Thomas KS; O'Donnell DM; Gonias SL
    J Biol Chem; 2003 Jan; 278(3):1642-6. PubMed ID: 12426305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A switch role of Src in the biphasic EGF signaling of ER-negative breast cancer cells.
    Zhang X; Meng J; Wang ZY
    PLoS One; 2012; 7(8):e41613. PubMed ID: 22927910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenously produced urokinase-type plasminogen activator is a major determinant of the basal level of activated ERK/MAP kinase and prevents apoptosis in MDA-MB-231 breast cancer cells.
    Ma Z; Webb DJ; Jo M; Gonias SL
    J Cell Sci; 2001 Sep; 114(Pt 18):3387-96. PubMed ID: 11591826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated urokinase-specific surface receptor expression is maintained through its interaction with urokinase plasminogen activator.
    Mahanivong C; Yu J; Huang S
    Mol Carcinog; 2007 Mar; 46(3):165-75. PubMed ID: 17186542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A direct link between expression of urokinase plasminogen activator receptor, growth rate and oncogenic transformation in mouse embryonic fibroblasts.
    Mazzieri R; Furlan F; D'Alessio S; Zonari E; Talotta F; Verde P; Blasi F
    Oncogene; 2007 Feb; 26(5):725-32. PubMed ID: 16878153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT5b, a Mediator of Synergism between c-Src and the Epidermal Growth Factor Receptor.
    Kloth MT; Laughlin KK; Biscardi JS; Boerner JL; Parsons SJ; Silva CM
    J Biol Chem; 2003 Jan; 278(3):1671-9. PubMed ID: 12429742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitogenic signaling of urokinase receptor-deficient kidney fibroblasts: actions of an alternative urokinase receptor and LDL receptor-related protein.
    Zhang G; Cai X; López-Guisa JM; Collins SJ; Eddy AA
    J Am Soc Nephrol; 2004 Aug; 15(8):2090-102. PubMed ID: 15284295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteopontin induces AP-1-mediated secretion of urokinase-type plasminogen activator through c-Src-dependent epidermal growth factor receptor transactivation in breast cancer cells.
    Das R; Mahabeleshwar GH; Kundu GC
    J Biol Chem; 2004 Mar; 279(12):11051-64. PubMed ID: 14704150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor receptor-mediated regulation of urokinase plasminogen activator expression and glioblastoma invasion via C-SRC/MAPK/AP-1 signaling pathways.
    Amos S; Redpath GT; Dipierro CG; Carpenter JE; Hussaini IM
    J Neuropathol Exp Neurol; 2010 Jun; 69(6):582-92. PubMed ID: 20467333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination.
    Festuccia C; Angelucci A; Gravina GL; Biordi L; Millimaggi D; Muzi P; Vicentini C; Bologna M
    Thromb Haemost; 2005 May; 93(5):964-75. PubMed ID: 15886816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protease-mediated human smooth muscle cell proliferation by urokinase requires epidermal growth factor receptor transactivation by triple membrane signaling.
    Duru EA; Fu Y; Davies MG
    J Surg Res; 2014 Dec; 192(2):254-62. PubMed ID: 25082749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator inhibitor 1 functions as a urokinase response modifier at the level of cell signaling and thereby promotes MCF-7 cell growth.
    Webb DJ; Thomas KS; Gonias SL
    J Cell Biol; 2001 Feb; 152(4):741-52. PubMed ID: 11266465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydrotestosterone potentiates EGF-induced ERK activation by inducing SRC in fetal lung fibroblasts.
    Lee MK; Smith SM; Murray S; Pham LD; Minoo P; Nielsen HC
    Am J Respir Cell Mol Biol; 2014 Jul; 51(1):114-24. PubMed ID: 24484548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells.
    Fox EM; Bernaciak TM; Wen J; Weaver AM; Shupnik MA; Silva CM
    Mol Endocrinol; 2008 Aug; 22(8):1781-96. PubMed ID: 18550772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D2A sequence of the urokinase receptor induces cell growth through αvβ3 integrin and EGFR.
    Eden G; Archinti M; Arnaudova R; Andreotti G; Motta A; Furlan F; Citro V; Cubellis MV; Degryse B
    Cell Mol Life Sci; 2018 May; 75(10):1889-1907. PubMed ID: 29184982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GEP100 regulates epidermal growth factor-induced MDA-MB-231 breast cancer cell invasion through the activation of Arf6/ERK/uPAR signaling pathway.
    Hu Z; Xu R; Liu J; Zhang Y; Du J; Li W; Zhang W; Li Y; Zhu Y; Gu L
    Exp Cell Res; 2013 Aug; 319(13):1932-1941. PubMed ID: 23747719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.